GE HealthCare Technologies Inc (GEHC) concluded trading on Wednesday at a closing price of $83.66, with 4.15 million shares of worth about $347.05 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.23% during that period and on January 15, 2025 the price saw a loss of about -0.56%. Currently the company’s common shares owned by public are about 456.85M shares, out of which, 442.48M shares are available for trading.
Stock saw a price change of 0.35% in past 5 days and over the past one month there was a price change of 2.49%. Year-to-date (YTD), GEHC shares are showing a performance of 7.01% which increased to 9.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $71.31 but also hit the highest price of $94.55 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 3.14 million. The stock is currently trading 3.55% above its 20-day simple moving average (SMA20), while that difference is up 1.40% for SMA50 and it goes to 0.20% higher than SMA200.
GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 456.85M outstanding shares and institutions hold larger chunk of about 80.99% of that.
The stock has a current market capitalization of $38.22B and its 3Y-monthly beta is at 1.23. PE ratio of stock for trailing 12 months is 22.91, while it has posted earnings per share of $3.65 in the same period. Its PEG reads 2.24 and has Quick Ratio of 0.94 while making debt-to-equity ratio of 1.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 2.84% while standing at 2.27% over the month.
Stock’s fiscal year EPS is expected to rise by 9.29% while it is estimated to increase by 8.55% in next year. EPS is likely to grow at an annualized rate of 10.24% for next 5-years, compared to annual growth of -2.54% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on January 08, 2025 offering a Buy rating for the stock and assigned a target price range of between $95 and $103 to it. Coverage by UBS stated GE HealthCare Technologies Inc (GEHC) stock as a Sell in their note to investors on September 26, 2024, suggesting a price target of $74 for the stock. On September 18, 2024, BTIG Research Upgrade their recommendations, while on September 09, 2024, JP Morgan Initiated their ratings for the stock with a price target of $90. Stock get a Buy rating from Stifel on August 06, 2024.
